We need slow and steady, FDA approved testing + Revenue1
st phase will see 11 covid-19 testing centres by QSC and in the Fall season (another Month) many more in 2
nd phase all over America. What this mean is revenue increasing with every new testing centres plus. QSC extending promissory note mean they are expecting more big sales so they can use that $7.7 million to buy more supply.
QSC generating revenue is not one day play, QSC is long term investment. Revenue from QuestCap owned testing centres plus now Real Estate Agents plus many deals like BioCorp Clinical Lab in California for 500,000 test kits is already lot more Revenue compare to QuestCap Market Cap. Collection Sites has launched COVID-19 testing services in conjunction with Alcala Testing and Analysis Services, a CLIA registered high complexity laboratory based in San Diego, Calif. It opened its first site on Aug. 8, 2020 and anticipates opening 10 more pop-up labs in its phase 1 rollout.
When completed, the 11 pop-up labs, also known as "draw centres," collectively will be able to administer up to 5,500 tests per day, with a capacity to analyze up to 154,000 test a month. Appointments and payments will be handled through an on-line portal.
The first site opened for business in Las Vegas on August 8, 2020. Additional locations are expected to open throughout
Las Vegas, as well as Arizona, Texas, and Indiana within the next couple of weeks. The draw centres will be located in malls, retail centers, fitness facilities, pharmacies, stadiums, on-site in small businesses, real estate offices, law firms and schools.
The second phase, expected to launch in fall 2020, will include mobile pop-up labs to provide access to those without transportation or unable to travel. Mr. Tim Shelburn, CEO of Collection Sites, LLC. “We are pleased to collaborate with our laboratory partner, Alcala, to establish pop-up testing centers across America.
https://stockhouse.com/news/press-releases/2020/08/11/questcap-announces-letter-of-intent-to-acquire-100-of-las-vegas-based